journal article Jul 01, 2009

Clusters of Multidrug-ResistantMycobacterium tuberculosisCases, Europe

View at Publisher Save 10.3201/eid1507.080994
Topics

No keywords indexed for this article. Browse by subject →

References
24
[1]
Aziz "Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis." Lancet (2006) 10.1016/s0140-6736(06)69863-2
[2]
Zignol "Global incidence of multidrug-resistant tuberculosis." J Infect Dis (2006) 10.1086/505877
[3]
World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. WHO/HTM/TB/Geneva; 2008.394.
[4]
World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: The Organization; 2006 [cited 2009 May 26]. Available from http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf
[5]
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
[6]
Shah "Worldwide emergence of extensively drug-resistant tuberculosis." Emerg Infect Dis (2007) 10.3201/eid1303.061400
[7]
Schwoebel "Standardisation of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union against Tuberculosis and Lung Disease (IUATLD) Working Group." Eur Respir J (2000)
[8]
Glynn "Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review." Emerg Infect Dis (2002) 10.3201/eid0808.020002
[9]
Murray "Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge." Bull World Health Organ (2002)
[10]
Tracevska "Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates." Int J Tuberc Lung Dis (2003)
[11]
Krüüner "Spread of drug-resistant pulmonary tuberculosis in Estonia." J Clin Microbiol (2001) 10.1128/jcm.39.9.3339-3345.2001
[12]
European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis "Beijing/W genotype Mycobacterium tuberculosis and drug resistance." Emerg Infect Dis (2006) 10.3201/eid1205.050400
[13]
EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Reports on multi-drug resistant tuberculosis. Institut de Veille Sanitaire, Saint-Maurice 2008; France [cited 2009 May 15]. Available from http://www.eurotb.org/mdr_tb_surveillance/pdf/MDR-TB_report6.pdf
[14]
Heersma "Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis." Methods Mol Biol (1998)
[15]
Laszlo "Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994–1998." Int J Tuberc Lung Dis (2002)
[16]
Laszlo "Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing." Int J Tuberc Lung Dis (1997)
[17]
EuroTB and the National Coordinators for Tuberculosis Surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006, Institut de Veille Sanitaire, Saint-Maurice, France. 2008 Mar.
[18]
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

J D van Embden, M D Cave, J T Crawford et al.

Journal of Clinical Microbiology 1993 10.1128/jcm.31.2.406-409.1993
[19]
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology

J Kamerbeek, L Schouls, A Kolk et al.

Journal of Clinical Microbiology 1997 10.1128/jcm.35.4.907-914.1997
[20]
Supply "Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units." J Clin Microbiol (2001) 10.1128/jcm.39.10.3563-3571.2001
[21]
Kremer "Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers." J Clin Microbiol (2004) 10.1128/jcm.42.9.4040-4049.2004
[22]
Manissero D, Fernandez de la Hoz K. Surveillance methods and case definition for extensively drug resistant TB (XDR-TB) and relevance to Europe: summary update. Euro Surveill 2006; 11(11):E061103.1. 10.2807/esw.11.44.03070-en
[23]
Supply "Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis." J Clin Microbiol (2006) 10.1128/jcm.01392-06
[24]
Lambregts-van Weezenbeek "Tuberculosis contact investigation and DNA fingerprint surveillance in the Netherlands: 6 years’ experience with nationwide cluster feedback and cluster monitoring." Int J Tuberc Lung Dis (2003)
Metrics
66
Citations
24
References
Details
Published
Jul 01, 2009
Vol/Issue
15(7)
Pages
1052-1060
Cite This Article
Isabelle Devaux, Kristin Kremer, Herre Heersma, et al. (2009). Clusters of Multidrug-ResistantMycobacterium tuberculosisCases, Europe. Emerging Infectious Diseases, 15(7), 1052-1060. https://doi.org/10.3201/eid1507.080994
Related

You May Also Like

Biofilms: Microbial Life on Surfaces

Rodney M. Donlan · 2002

3,800 citations

Global Spread of Carbapenemase-producingEnterobacteriaceae

Patrice Nordmann, Thierry Naas · 2011

1,943 citations

Biofilms and Device-Associated Infections

Rodney M. Donlan · 2001

1,118 citations

The Changing Epidemiology of Staphylococcus aureus?

Henry F. Chambers · 2001

1,018 citations